DK0060257814
DK0060257814
Zealand Pharma A/S
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 9.214.860.000 | 62.691.000 | 14598.9% |
| Cost of Revenue | 816.000 | 7.874.000 | 89.6% |
| Gross Profit | 9.214.044.000 | 54.817.000 | 16708.7% |
| 2.100.521.000 | 1.323.888.000 | 58.7% | |
| Operating Income | 7.113.523.000 | -1.269.071.000 | 660.5% |
| Pretax Income | 7.001.065.000 | -1.083.445.000 | 746.2% |
| Net Income Common Stockholders | 6.455.008.000 | -1.078.828.000 | 698.3% |
| -- | -- | -- | |
| -- | -- | -- |